Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Sideris

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|July 26, 2008
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysisEric Marcotte, Lucas Sideris, Pierre Drolet, et al.
The American Journal of Case Reports|November 9, 2025
Use of Neoadjuvant Immunotherapy in Malignant Peritoneal Mesothelioma as a Bridge to Surgical Intervention: A Case ReportSohayb Faleh, Tanya Odisho, Florence Lebel-Guay, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 2, 2021
Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative studyElla Benzaquen, Yifan Wang, Stephanie Wiseman, et al.
Annals of Surgical Oncology|May 5, 2004
Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trialsDominique Elias, Jean-Robert Delperro, Lucas Sideris, et al.
World Journal of Surgical Oncology|November 9, 2014
Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysisEric Marcotte, Pierre Dubé, Pierre Drolet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 25, 2025
Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastasesGiancarlo Sticca, Mikael Soucisse, Maria Abou-Khalil, et al.
Annals of Surgical Oncology|March 3, 2004
Results of R0 resection for colorectal liver metastases associated with extrahepatic diseaseDominique Elias, Lucas Sideris, Marc Pocard, et al.
International Journal of Surgical Oncology|September 13, 2012
Surgery should complement endocrine therapy for elderly postmenopausal women with hormone receptor-positive early-stage breast cancerOlivier Nguyen, Lucas Sideris, Pierre Drolet, et al.
Annals of Surgical Oncology|September 30, 2025
Radiologic and Pathologic Response as Predictors of Survival in Patients with Colorectal Peritoneal Metastases Undergoing Neoadjuvant Chemotherapy Followed by CRS-HIPEC: A Retrospective StudyJessica Cyr-Cronier, Florence Lebel-Guay, Lucas Sideris, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 9, 2016
Electrocautery effect on intestinal vascularisation in a murine modelJean-François Tremblay, Lucas Sideris, François A Leblond, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|July 26, 2008
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysisEric Marcotte, Lucas Sideris, Pierre Drolet, et al.
The American Journal of Case Reports|November 9, 2025
Use of Neoadjuvant Immunotherapy in Malignant Peritoneal Mesothelioma as a Bridge to Surgical Intervention: A Case ReportSohayb Faleh, Tanya Odisho, Florence Lebel-Guay, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 2, 2021
Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative studyElla Benzaquen, Yifan Wang, Stephanie Wiseman, et al.
Annals of Surgical Oncology|May 5, 2004
Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trialsDominique Elias, Jean-Robert Delperro, Lucas Sideris, et al.
World Journal of Surgical Oncology|November 9, 2014
Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysisEric Marcotte, Pierre Dubé, Pierre Drolet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 25, 2025
Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastasesGiancarlo Sticca, Mikael Soucisse, Maria Abou-Khalil, et al.
Annals of Surgical Oncology|March 3, 2004
Results of R0 resection for colorectal liver metastases associated with extrahepatic diseaseDominique Elias, Lucas Sideris, Marc Pocard, et al.
International Journal of Surgical Oncology|September 13, 2012
Surgery should complement endocrine therapy for elderly postmenopausal women with hormone receptor-positive early-stage breast cancerOlivier Nguyen, Lucas Sideris, Pierre Drolet, et al.
Annals of Surgical Oncology|September 30, 2025
Radiologic and Pathologic Response as Predictors of Survival in Patients with Colorectal Peritoneal Metastases Undergoing Neoadjuvant Chemotherapy Followed by CRS-HIPEC: A Retrospective StudyJessica Cyr-Cronier, Florence Lebel-Guay, Lucas Sideris, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 9, 2016
Electrocautery effect on intestinal vascularisation in a murine modelJean-François Tremblay, Lucas Sideris, François A Leblond, et al.
Pageof 7